Checkpoint Therapeutics earnings were -$56.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CKPT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$28.9M, up 197.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CKPT reported annual earnings of -$56.2M, with 8.5% growth. The next CKPT earnings date is May 8, 2025.
Checkpoint Therapeutics Earnings Reports & History FAQ
What were Checkpoint Therapeutics's earnings last quarter?
On CKPT's earnings call on Invalid Date, Checkpoint Therapeutics (NASDAQ: CKPT) reported Q4 2024 earnings per share (EPS) of -$0.69, up 37.27% year over year. Total CKPT earnings for the quarter were -$28.90 million. In the same quarter last year, Checkpoint Therapeutics's earnings per share (EPS) was -$1.10.
When does Checkpoint Therapeutics report earnings?
The next CKPT earnings call is Invalid Date. Add CKPT to your watchlist to be reminded of Checkpoint Therapeutics's next earnings date.
What was CKPT's earnings growth in the past year?
As of Checkpoint Therapeutics's earnings date in Invalid Date, Checkpoint Therapeutics's earnings has grown year over year. CKPT earnings in the past year totalled -$56.24 million.
Is Checkpoint Therapeutics profitable or losing money?
As of the last Checkpoint Therapeutics earnings report, Checkpoint Therapeutics is currently losing money. Checkpoint Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$56.24 million, a 8.47% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.